|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current Assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total cash and cash equivalents | ||||||||||||||||||||
| Series B Convertible Preferred Stock proceeds receivable (Note 18 and 20) | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total accounts receivable | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Forward purchase receivable | ||||||||||||||||||||
| Short-term loans receivable | ||||||||||||||||||||
| Asset held for sale | ||||||||||||||||||||
| Loans receivable, net | ||||||||||||||||||||
| Contract asset | ||||||||||||||||||||
| Investment in preferred securities | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Long-term loans receivable, net | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Operating lease right to use asset | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Developed Technology | ||||||||||||||||||||
| Deferred tax asset, net | ||||||||||||||||||||
| Investment in preferred securities | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Forward purchase receivable | ||||||||||||||||||||
| Security deposit | ||||||||||||||||||||
| Contract asset | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Current Liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total accounts payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Contract liabilities | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Operating lease liability | ||||||||||||||||||||
| Senior secured promissory note | ||||||||||||||||||||
| Deferred consideration | ||||||||||||||||||||
| Forward purchase derivative liability | ||||||||||||||||||||
| Stand-ready guarantee liability | ||||||||||||||||||||
| Financial indemnification liability | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Deferred consideration – long term portion | ||||||||||||||||||||
| Forward purchase derivative liability | ||||||||||||||||||||
| Senior secured promissory note | ||||||||||||||||||||
| Net deferred indemnified loan origination fees | ||||||||||||||||||||
| Stand-ready guarantee liability | ||||||||||||||||||||
| Financial indemnification liability | ||||||||||||||||||||
| Operating lease liability | ||||||||||||||||||||
| Indemnity liability | ||||||||||||||||||||
| Warrant liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Stockholders’ Equity | ||||||||||||||||||||
| Convertible preferred stock, value | ||||||||||||||||||||
| Series B Convertible Preferred Stock | ||||||||||||||||||||
| Class A Common Stock, $.0001 par value, 1,000,000,000 shares authorized, 12,332,955 and 4,281,523 issued and outstanding on June 30, 2026, and December 31, 2025, respectively | ||||||||||||||||||||
| Total class A Common Stock, $.0001 par value, 1,000,000,000 shares authorized, 12,332,955 and 4,281,523 issued and outstanding on June 30, 2026, and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total Stockholders’ Equity | ||||||||||||||||||||
| Total Liabilities and Stockholders’ Equity | ||||||||||||||||||||
Loading...